230JPY
4.24 BJPY
60.46 BJPY
13.38 M
About ASKA PHARMACEUTICAL HOLDINGS CO LTD
Sector
Headquarters
Tokyo
Employees (FY)
747
Website
ISIN
JP3119660003
FIGI
BBG00SR9MPQ1
ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. It operates through the Pharmaceutical and Other segments. The Pharmaceutical segment manufactures and sells pharmaceutical products. The Other segment includes veterinary drug, clinical testing, outsourcing, health food, and medical equipment businesses. The company is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4886 is 2264 JPY — it has increased by 0.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ASKA PHARMACEUTICAL HOLDINGS CO LTD stocks are traded under the ticker 4886.
ASKA PHARMACEUTICAL HOLDINGS CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4886 stock is 3.58% volatile and has beta coefficient of 0.32. Check out the list of the most volatile stocks — is ASKA PHARMACEUTICAL HOLDINGS CO LTD there?
ASKA PHARMACEUTICAL HOLDINGS CO LTD revenue for the last quarter amounts to 15.63 B JPY despite the estimated figure of 15.68 B JPY. In the next quarter revenue is expected to reach 17.48 B JPY.
Yes, you can track ASKA PHARMACEUTICAL HOLDINGS CO LTD financials in yearly and quarterly reports right on TradingView.
4886 stock has risen by 1.98% compared to the previous week, the month change is a 5.35% rise, over the last year ASKA PHARMACEUTICAL HOLDINGS CO LTD has showed a 81.99% increase.
4886 net income for the last quarter is 2.33 B JPY, while the quarter before that showed 2.70 B JPY of net income which accounts for −13.77% change. Track more ASKA PHARMACEUTICAL HOLDINGS CO LTD financial stats to get the full picture.
Today ASKA PHARMACEUTICAL HOLDINGS CO LTD has the market capitalization of 63.43 B, it has decreased by 1.81% over the last week.
ASKA PHARMACEUTICAL HOLDINGS CO LTD dividend yield was 1.35% in 2022, and payout ratio reached 10.66%. The year before the numbers were 1.19% and 9.92% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4886 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASKA PHARMACEUTICAL HOLDINGS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 747.00 employees. See our rating of the largest employees — is ASKA PHARMACEUTICAL HOLDINGS CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASKA PHARMACEUTICAL HOLDINGS CO LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASKA PHARMACEUTICAL HOLDINGS CO LTD stock shows the buy signal. See more of ASKA PHARMACEUTICAL HOLDINGS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ASKA PHARMACEUTICAL HOLDINGS CO LTD future price: according to them, 4886 price has a max estimate of 3100.00 JPY and a min estimate of 2400.00 JPY. Read a more detailed ASKA PHARMACEUTICAL HOLDINGS CO LTD forecast: see what analysts think of ASKA PHARMACEUTICAL HOLDINGS CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASKA PHARMACEUTICAL HOLDINGS CO LTD EBITDA is 8.50 B JPY, and current EBITDA margin is 13.62%. See more stats in ASKA PHARMACEUTICAL HOLDINGS CO LTD financial statements.